Radiation oncologist; Artera clinical development team
Charlottesville, VA
Joined May 2018
- Tweets344
- Following744
- Followers1.2K
- Likes1.8K
Tim Showalter retweeted
In this episode we chat w @othman CEO/cofounder @Color - give us a listen for a story of impact and inspiration for how health technology can improve care delivery podcasts.apple.com/us/podcas…
Tim Showalter retweeted
We’re proud to have @Benioff on Artera’s board, helping shape how AI transforms precision medicine.
Check out his latest interview on the future of AI in business via @ChiefExecGrp: heyor.ca/mpLN8u
#AIinHealthcare #MarcBenioff #Leadership
Tim Showalter retweeted
Congratulations to our friends and colleagues @arteraAI —their multimodal #ArtificialInteligence platform is revolutionary and applicable clinically. Bravo @arteraAI team! @TIME
time.com/7094698/arterai-mul…
Tim Showalter retweeted
Dr. @TimShowalter1 from @arteraAI presented the data from prostate cancer and discussed possibilities of integrating tissue AI analysis in RCC. Very promising to have AI integration in RCC. #KCRS23 @OncoAlert
Tim Showalter retweeted
Can we take lessons learned from #prostatecancer into #kidneycancer?
@TimShowalter1 says yes!
@kidneycan @kidneycancer @kcCURE #KCRS23
Thank you for the invitation to share the potential impact we can make together for patients with #RCC #KCRS23 @arteraAI
Elegant talk on how #AI can guide development of biomarkers in #RCC by @TimShowalter1
#KCRS23 @OncoAlert @kidneycan
So excited to take on this exciting role with a tremendous team of new friends and some old colleagues! @NGThaker_XRT @dougfloramd @scottpenberthy
ArteraAI is proud to announce that our own Tim Showalter MD, MPh, is part of the groundbreaking new academic journal - the only peer-reviewed research journal dedicated to the advancement of #AI applications in clinical & precision #oncology: bit.ly/3PuAjIk
Amazing work with direct clinical impact! Congrats to @DrSpratticus @NRGonc and the team at @arteraAI
This report used data derived and validated from completed randomized phase III trials to demonstrate that an AI-based predictive model could identify pts with predominately intermediate-risk #ProstateCancer who are likely to benefit from short-term androgen deprivation therapy.
Tim Showalter retweeted
Are you passionate about #artificialintelligence and innovation in medical care? Join our team!
Are you looking to make a difference with your career? #ArteraAI is seeking a #ClinicalResearch Associate.
➡️ Get full job details and apply here today: bit.ly/3PhrDVr
ALT An ArteraAI Careers graphic promoting the Clinical Reseach Associate position.
So much fun getting to be a shark for this! Exciting to see the potential impact of AI in brachytherapy. Congratulations to all three of the presenters for compelling proposals and pitches.
Shark tank at ABS#2023 presentation on Chat GPT for brachy education @TimShowalter1 @PranshuMohindra
Tim Showalter retweeted
Shark tank at ABS#2023 presentation on Chat GPT for brachy education @TimShowalter1 @PranshuMohindra
Congrats to Kara and the UVA team on completing the trial! Very excited to see the great results
@romano_kara found BrachyGel packing is preferred by brachytherapists & patients with no difference in dose to the cervix or OAR! #ABSBrachy23
Tim Showalter retweeted
Did you catch Tim Showalter's presentation at #BiomarkersSeries23? 🇬🇧
Members of the Artera team met with attendees to discuss how the #ArteraAI #ProstateTest can help identify patients who will benefit from therapy intensification.
➡️ Learn more: artera.ai/our-test/
Tim Showalter retweeted
What if there was a way to identify the patients who would benefit from therapy intensification?
With #ArteraAI, there is. 💙
➡️ Learn more about The ArteraAI #ProstateTest: artera.ai/our-test
Tim Showalter retweeted
The Artera team is heading to #BiomarkersSeries23 2/27-2/28 in Manchester. 🇬🇧
Don't miss Dr. Tim Showalter's presentation "Pathology-Based Deep Learning Tools to Personalize Treatment Decisions: #ArteraAI #ProstateTest Development & Validation" on 2/27! bit.ly/3XEatCb
Tim Showalter retweeted
🏎️ FORMULA 509 @DrPaulNguyen #GU23 #pcsm @OncoAlert
Salvage RT (med dose 68.4 Gy, 26% nodes tx) w 6 mos ADT ±intensification w AAP/Apa
Overall PFS HR 0.71 p=.06
However pre-specified subgrp PSA>0.5 PFS HR 0.5, P=.03; MFS HR 0.32 p=.02 👉 potential alt to longer ADT in this pop
Tim Showalter retweeted
#ArteraAI is at #GU23!
Don't miss today's presentation with @DrSpratticus, as he shares results from six phase III randomized trials and how the use of MMAI prognostic biomarkers may improve the ability to assess risk in patients with #prostatecancer.⚕️ #ASCOGU
Tim Showalter retweeted
Thrilled to see a great turnout for the amazing IBC update from the incomparable @FilipaLynce @IBC_DanaFarber highlighting progress in biology, partnership with @SusanGKomen @MDAndersonNews for diagnosis tools and efforts to move good M1 tx to the M0 IBC setting! #SABCS2022
Tim Showalter retweeted
More science highlights from ASTRO on UroToday! #ASTRO22 #ASTRO2022 #AI #ArteraAI
urotoday.com/conference-high… via @urotoday